<SEC-DOCUMENT>0000818479-22-000031.txt : 20220419
<SEC-HEADER>0000818479-22-000031.hdr.sgml : 20220419
<ACCEPTANCE-DATETIME>20220419165016
ACCESSION NUMBER:		0000818479-22-000031
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20220416
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220419
DATE AS OF CHANGE:		20220419

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DENTSPLY SIRONA Inc.
		CENTRAL INDEX KEY:			0000818479
		STANDARD INDUSTRIAL CLASSIFICATION:	DENTAL EQUIPMENT & SUPPLIES [3843]
		IRS NUMBER:				391434669
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-16211
		FILM NUMBER:		22835410

	BUSINESS ADDRESS:	
		STREET 1:		13320 BALLANTYNE CORPORATE PLACE
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28277-3607
		BUSINESS PHONE:		844-546-3722

	MAIL ADDRESS:	
		STREET 1:		13320 BALLANTYNE CORPORATE PLACE
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28277-3607

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DENTSPLY INTERNATIONAL INC /DE/
		DATE OF NAME CHANGE:	19930630

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENDEX CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>xray-20220416.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:97ea7f8f-ff86-4c34-be4c-873ef9505afa,g:f3ae1ec0-38c5-41c5-9ea8-168f861349c2,d:2b88dce5853c480cbeb75588f15674b8--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>xray-20220416</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF80L2ZyYWc6OWJjZTE2ZDM2YTYxNDMyOWFjOWUxMGI5NjIyNmE3NjkvdGFibGU6NGY4NjljOTkxNzk3NGIwM2FmZTQ4NWQxMzY3NDNiZWEvdGFibGVyYW5nZTo0Zjg2OWM5OTE3OTc0YjAzYWZlNDg1ZDEzNjc0M2JlYV8wLTEtMS0xLTgzNDA3_c832c17d-1e0b-44d1-bba7-d00b9cec0b1a">0000818479</ix:nonNumeric><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF80L2ZyYWc6OWJjZTE2ZDM2YTYxNDMyOWFjOWUxMGI5NjIyNmE3NjkvdGFibGU6NGY4NjljOTkxNzk3NGIwM2FmZTQ4NWQxMzY3NDNiZWEvdGFibGVyYW5nZTo0Zjg2OWM5OTE3OTc0YjAzYWZlNDg1ZDEzNjc0M2JlYV8xLTEtMS0xLTgzNDA3_c0a231e5-ff7d-49d0-8f75-973ee4a5b598">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="xray-20220416.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000818479</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-16</xbrli:startDate><xbrli:endDate>2022-04-16</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i2b88dce5853c480cbeb75588f15674b8_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%">FORM <ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF8xNTk4_36d6e7b8-8384-4297-825f-44a783c1b505">8-K</ix:nonNumeric></span></div><div style="margin-top:11pt;padding-left:108pt;padding-right:108pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:11pt;padding-left:108pt;padding-right:108pt;text-align:center"><span><br/></span></div><div style="margin-top:1pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">April 19, 2022 (<ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF8xNjAw_97616079-1316-4da2-8d4f-65c2d25b136d">April 16, 2022</ix:nonNumeric>)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%;text-decoration:underline"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF8xNjAx_b3f5966f-10cb-436f-b27c-ea478c990d00">DENTSPLY SIRONA Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(Exact name of registrant as specified in its charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18wLTAtMS0xLTgzNDA3_d669b1a7-d5fc-4506-a39a-3d213defe8bb">Delaware</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18wLTEtMS0xLTgzNDA3_85f4b7b6-42c9-4531-aba2-5ce0338f8851">0-16211</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18wLTMtMS0xLTgzNDA3_ed361c23-8626-4445-a84d-a25ef2c032e2">39-1434669</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18zLTAtMS0xLTgzNDA3_eb56c063-6547-448e-8f03-e57d0457879b">13320 Ballantyne Corporate Place,</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18zLTEtMS0xLTgzNDA3_2a840432-858f-4e8e-b789-bca1c4f32bf8">Charlotte</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18zLTItMS0xLTgzNDA3_8e4e8d8a-3319-40d5-9c5b-9266f3c28501">North Carolina</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18zLTMtMS0xLTgzNDA3_8e4956e0-f86f-4728-bb26-59ea0099e0a5">28277-3607</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%;text-decoration:underline"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF8xNjAy_eaa12c7c-0332-4a98-a713-c2bdb835fb1b">844)</ix:nonNumeric> <ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF8xNjAz_9852a681-95fa-47ed-9303-fc0e769e52ab">848-0137</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(Registrant's telephone number, including area code)</span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF82MTY_6f3f3e15-1c9b-4420-bb24-3660edcbc120">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF83MDY_48f1d321-9c09-440d-8e18-a6246b8d4580">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF83OTg_de21bdc1-8184-44d0-9167-3138772d6a76">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF85MDY_29d4628d-25cd-481c-9c20-53aecb01afbf">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Mjg2YTI0NmViNTBjNDA3YmIyMTY1ZTUwZjNjYWI2ZmIvdGFibGVyYW5nZToyODZhMjQ2ZWI1MGM0MDdiYjIxNjVlNTBmM2NhYjZmYl8xLTAtMS0xLTgzNDA3_198e2305-b854-4249-8486-a0554ab928b3">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Mjg2YTI0NmViNTBjNDA3YmIyMTY1ZTUwZjNjYWI2ZmIvdGFibGVyYW5nZToyODZhMjQ2ZWI1MGM0MDdiYjIxNjVlNTBmM2NhYjZmYl8xLTEtMS0xLTgzNDA3_0b66e601-6b58-45e2-be23-fb956b56c6b5">XRAY</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Mjg2YTI0NmViNTBjNDA3YmIyMTY1ZTUwZjNjYWI2ZmIvdGFibGVyYW5nZToyODZhMjQ2ZWI1MGM0MDdiYjIxNjVlNTBmM2NhYjZmYl8xLTItMS0xLTgzNDA3_d2240ff2-ae10-4884-bed2-6a8618bd9758">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="text-align:right"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF8xMzQw_d9ef22e7-22cf-4d6d-b19b-5ac42a830e38">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:right"><span><br/></span></div><div id="i2b88dce5853c480cbeb75588f15674b8_7"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02 Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information is furnished pursuant to Item 2.02, &#8220;Results of Operations and Financial Condition.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 19, 2022, DENTSPLY SIRONA Inc. (the &#8220;Company&#8221;) issued a press release announcing select preliminary financial results, including net sales, U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) diluted earnings per share and adjusted earnings per share for the first quarter ending March 31, 2022. A copy of the Company's press release is attached hereto as Exhibit 99.1 and is hereby incorporated by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has provided certain measures in the press release that are not calculated in accordance with GAAP and therefore represent Non-GAAP measures. These Non-GAAP measures may differ from those used by other companies and should not be considered in isolation from, or as a substitute for, measures of financial performance prepared in accordance with GAAP. These Non-GAAP measures are used by the Company to measure its performance and may differ from those used by other companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that these Non-GAAP measures are helpful as they provide another measure of the results of operations, and are frequently used by investors and analysts to evaluate the Company&#8217;s performance exclusive of certain items that impact the comparability of results from period to period, and which may not be indicative of past or future performance of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not able to reconcile projected adjusted earnings per share (non-GAAP) to first quarter 2022 projected earnings per share (GAAP) without unreasonable efforts because it is not possible to predict with a reasonable degree of certainty the actual impact of the tax rate and related matters for the quarter ended March 31, 2022. The unavailable information could have a significant impact on the Company&#8217;s first quarter 2022 reported financial results.</span></div><div><span><br/></span></div><div id="i2b88dce5853c480cbeb75588f15674b8_10"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 19, 2022, the Company announced that Donald M. Casey Jr. has been terminated as the Company&#8217;s Chief Executive Officer and has ceased to serve as a member of the Board of Directors of the Company, effective as of April 19, 2022. Mr. Casey has served as the Company&#8217;s Chief Executive Officer since joining the Company in February 2018. The Company has initiated a search process to identify its next Chief Executive Officer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective immediately, John P. Groetelaars, who serves as a member of the Board of Directors of the Company, has been named Interim Chief Executive Officer and principal executive officer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Groetelaars, age 56, served as President, CEO and a Board member at Hillrom from May 2018 until the company&#8217;s acquisition by Baxter International, Inc. in December 2021. At Hillrom, Mr. Groetelaars led a transformation of the business, successfully articulating and launching a new connected-care strategy and vision, growing the portfolio through seven acquisitions and one divestiture, and driving record financial performance. Prior to Hillrom, Mr. Groetelaars served as Executive Vice President and President of the Interventional Segment at Becton, Dickinson and Company following its acquisition of C.R. Bard Inc. He previously served in a variety of progressive roles at C.R. Bard during his 10-year career there, including as a group president from 2015 to 2017. Prior to joining C.R. Bard, Mr. Groetelaars held various international leadership positions in Canada, Denmark and the United Kingdom at Boston Scientific Corporation from 2001 until 2008. Prior to joining Boston Scientific, Mr. Groetelaars held positions in general management, marketing, business development and sales with Guidant Corporation and with Eli Lilly. Mr. Groetelaars earned a Bachelor of Science in Mechanical Engineering from Kettering University and an MBA from Columbia Business School.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, effective on the earlier of (i) the effective date of termination of employment of the individual who was serving as the Company&#8217;s Chief Financial Officer and (ii) the close of business on May 6, 2022, Barbara W. Bodem will become the Company&#8217;s Interim Chief Financial Officer and principal financial officer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Bodem, age 54, most recently served as Senior Vice President and Chief Financial Officer for Hillrom, where she was responsible for both Financial and Information Technology and oversaw portfolio transformation and performance acceleration. She also served as Interim CIO during the pandemic. Prior to her positions at Hillrom, Ms. Bodem served as Senior Vice President of Finance for Mallinckrodt Pharmaceuticals, Vice President of Finance, Global Commercial Operations for Hospira, and at several positions of increasing responsibility at Eli Lilly and Company, culminating in Chief Financial Officer, Lilly </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Oncology. Ms. Bodem also has extensive Board experience, and currently serves as Audit Committee Chair for Turning Point Therapeutics, as a Director on Syneos&#8217; Board, and as a Director on Enovis Corporation&#8217;s Board. She has also previously served as a board member for Invacare Corporation. Ms. Bodem earned and a Bachelor of Science in Finance with honors and minors in Economics and East Asian Studies, as well as an MBA from Indiana University.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into interim employment agreements with each of Mr. Groetelaars and Ms. Bodem on April 16, 2022 (the &#8220;Agreements&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Groetelaars&#8217; Agreement provides that Mr. Groetelaars will serve as the Company&#8217;s Interim Chief Executive Officer commencing on April 19, 2022 and will report to the Company&#8217;s Board of Directors. Mr. Groetelaars will cease to be the Company&#8217;s Interim Chief Executive Officer on the first day a permanent or successor Chief Executive Officer approved by the Company&#8217;s Board of Directors commences employment with the Company and, unless otherwise determined by the Company&#8217;s Board of Directors, Mr. Groetelaars will cease to be employed by the Company on such date. Mr. Groetelaars&#8217; employment with the Company is &#8220;at-will,&#8221; such that his employment may be terminated by the Company or by Mr. Groetelaars at any time and for any reason. Pursuant to Mr. Groetelaars&#8217; Agreement, Mr. Groetelaars will be granted an award of restricted share units (&#8220;RSUs&#8221;) under the Company&#8217;s 2016 Omnibus Incentive Plan, as amended and restated (the &#8220;Plan&#8221;) having a grant date fair value of $7 million (the &#8220;Interim CEO Initial RSU Grant&#8221;). The number of shares subject to the Interim CEO Initial RSU Grant will be calculated by dividing (x) $7 million by (y) the closing price of a Company share as listed on The Nasdaq Global Select Market on the grant date. The Interim CEO Initial RSU Grant will vest monthly in six substantially equal installments, with the first vesting date occurring on the one month anniversary of Mr. Groetelaars&#8217; employment commencement date, such that 100% of the shares subject to the Interim CEO Initial RSU Grant will be vested on the sixth month anniversary of Mr. Groetelaars&#8217; employment commencement date (the &#8220;Interim CEO Final Vesting Date&#8221;), subject to Mr. Groetelaars&#8217; continued employment with the Company on each applicable vesting date as Interim Chief Executive Officer. However, upon (i) the consummation of a Change in Control (as defined in Mr. Groetelaars&#8217; Agreement) of the Company, (ii) Mr. Groetelaars ceasing to serve as the Company&#8217;s Interim Chief Executive Officer, or (iii) Mr. Groetelaars&#8217; termination of employment with the Company, in each case, before the Interim CEO Final Vesting Date for any reason other than (x) a termination by the Company or its affiliates for &#8220;Cause&#8221; (as defined in Mr. Groetelaars&#8217; Agreement) or (y) a voluntary resignation by Mr. Groetelaars (excluding a termination of Mr. Groetelaars&#8217; employment with the Company due to Mr. Groetelaars&#8217; death or disability), 100% of any then-unvested portion of the Interim CEO Initial RSU Grant will become vested, subject to Mr. Groetelaars&#8217; timely execution and non-revocation of a release of claims. Generally, the termination of Mr. Groetelaars&#8217; employment or cessation of his service as Interim Chief Executive Officer, in each case, in connection with the appointment of a permanent Chief Executive Officer of the Company will result in the accelerated vesting of 100% of the then-unvested portion of the Interim CEO Initial RSU Grant. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, following the Interim CEO Final Vesting Date, Mr. Groetelaars continues to be employed by the Company as its Interim Chief Executive Officer under the Agreement, then as consideration for Mr. Groetelaars&#8217; continued employment as the Company&#8217;s Interim Chief Executive Officer through any monthly anniversary of the Interim CEO Final Vesting Date, the Company will grant to Mr. Groetelaars an award of fully vested shares under the Plan on the first day of the calendar month following the applicable monthly anniversary of the Interim CEO Final Vesting Date (each, an &#8220;Interim CEO Subsequent Equity Grant&#8221;). Each Interim CEO Subsequent Equity Grant will have a grant date fair value of $1,166,667, with the number of shares calculated by dividing (x) $1,166,667 by (y) the closing price of a Company share as listed on The Nasdaq Global Select Market on the grant date (or the immediately preceding trading date, if the grant date is not a trading date). However, Mr. Groetelaars&#8217; entitlement to any Interim CEO Subsequent Equity Grants will end, and Mr. Groetelaars will have no further entitlement to any Company equity grants under the Agreement, following the earliest of (i) the appointment of a permanent Chief Executive Officer of the Company prior to an applicable monthly anniversary of the Interim CEO Final Vesting Date; (ii) Mr. Groeteleaars&#8217; termination of employment with the Company for any reason prior to an applicable monthly anniversary of the Interim CEO Final Vesting Date and (iii) the first day of the seventh full calendar month following the Interim CEO Final Vesting Date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent Mr. Groetelaars&#8217; employment as the Company&#8217;s Interim Chief Executive Officer causes him to forfeit certain group health plan insurance coverage for him and his eligible dependents that he would otherwise have been entitled to receive in connection with his separation from a prior employer, the Company and Mr. Groetelaars will make arrangements in good faith to compensate him for such forfeiture or provide him with substantially similar group health plan insurance coverage. The Company will also reimburse Mr. Groetelaars for reasonable travel and business expenses incurred in the performance of his duties, including travel to any of the Company&#8217;s offices other than Mr. Groetelaars&#8217; principal office, provided that, for all business air travel, Mr. Groetelaars will be entitled to travel by first class or business class commercial flights or private air travel. Mr. Groetelaars will not be eligible to receive any compensation for his service on the Company&#8217;s Board of Directors while he is employed as the Company&#8217;s Interim Chief Executive Officer.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of Mr. Groeteleaars&#8217; employment agreement is qualified in its entirety by reference to the text of the Mr. Groetelaars&#8217; Agreement filed as Exhibit 10.1 and incorporated herein by reference.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Groeteleaars does not have any family relationship with any director or executive officer of the Company, or person nominated or chosen by the Company to become a director or executive officer, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will also enter into its standard form of indemnification agreement with Mr. Groetelaars, the form of which is filed as Exhibit 10.19(b) to the Company&#8217;s Form 10-K for the period ended December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Bodem&#8217;s Agreement provides that Ms. Bodem will commence employment with the Company on April 25, 2022 and Ms. Bodem will be appointed as the Company&#8217;s Interim Chief Financial Officer effective on the earlier of (i) the effective date of termination of employment of the individual who was previously serving as the Company&#8217;s Chief Financial Officer and (ii) the close of business on May 6, 2022. Ms. Bodem will report to the Company&#8217;s Interim Chief Executive Officer or Chief Executive Officer (as applicable). Additionally, Ms. Bodem will cease to be the Company&#8217;s Interim Chief Financial Officer on the first day a permanent or successor Chief Financial Officer approved by the Company&#8217;s Board of Directors commences employment with the Company and, unless otherwise determined by the Company&#8217;s Board of Directors, Ms. Bodem will cease to be employed by the Company on such date. Ms. Bodem&#8217;s employment with the Company is &#8220;at-will,&#8221; such that her employment may be terminated by the Company or by Ms. Bodem at any time and for any reason.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Ms. Bodem&#8217;s Agreement, Ms. Bodem will receive a cash payment of $100,000, less applicable deductions and withholdings (the &#8220;Monthly Payment&#8221;) for each month she is employed as the Company&#8217;s Interim Chief Financial Officer for at least one day, provided that she will receive a Monthly Payment for the one month period starting on her employment commencement date regardless of whether she serves as the Company&#8217;s Interim Chief Financial Officer during such month. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Bodem will also be granted an award of RSUs under the Plan having a grant date fair value of $2 million (the &#8220;Interim CFO Initial RSU Grant&#8221;). The number of shares subject to the Interim CFO Initial RSU Grant will be calculated by dividing (x) $2,000,000 by (y) the closing price of a Company share as listed on The Nasdaq Global Select Market on the grant date. The Interim CFO Initial RSU Grant will vest monthly in six substantially equal installments, with the first vesting date occurring on the one month anniversary of Ms. Bodem&#8217;s employment commencement date, such that 100% of the shares subject to the Interim CFO Initial RSU Grant will be vested on the 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> month anniversary of Ms. Bodem&#8217;s employment commencement date (the &#8220;Interim CFO Final Vesting Date&#8221;), subject to Ms. Bodem&#8217;s continued employment with the Company on each applicable vesting date as Interim Chief Financial Officer. However, upon (i) the consummation of a Change in Control (as defined in Ms. Bodem&#8217;s Agreement) of the Company, (ii) Ms. Bodem ceasing to serve as the Company&#8217;s Interim Chief Financial Officer, or (iii) Ms. Bodem&#8217;s termination of employment with the Company, in each case, before the Interim CFO Final Vesting Date for any reason other than (x) a termination by the Company or its affiliates for &#8220;Cause&#8221; (as defined in the Agreement) or (y) a voluntary resignation by Ms. Bodem (excluding a termination of Ms. Bodem&#8217;s employment with the Company due to Ms. Bodem&#8217;s death or disability), 100% of any then-unvested portion of the Interim CFO Initial RSU Grant will become vested, subject to Ms. Bodem&#8217;s timely execution and non-revocation of a release of claims. Generally, the termination of Ms. Bodem&#8217;s employment or cessation of her service as Interim Chief Financial Officer, in each case, in connection with the appointment of a permanent Chief Financial Officer of the Company will result in the accelerated vesting of 100% of the then-unvested portion of the Interim CFO Initial RSU Grant. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, following the Interim CFO Final Vesting Date, Ms. Bodem continues to be employed by the Company as its Interim Chief Financial Officer under the Agreement, then as consideration for Ms. Bodem&#8217;s continued employment as the Company&#8217;s Interim Chief Financial Officer through any monthly anniversary of the Interim CFO Final Vesting Date, the Company will grant to Ms. Bodem an award of fully vested shares under the Plan on the first day of the calendar month following the applicable monthly anniversary of the Interim CFO Final Vesting Date (each, an &#8220;Interim CFO Subsequent Equity Grant&#8221;). Each Interim CFO Subsequent Equity Grant will have a grant date fair value of $333,333, with the number of shares calculated by dividing (x) $333,333 by (y) the closing price of a Company share as listed on The Nasdaq Global Select Market on the grant date (or the immediately preceding trading date, if the grant date is not a trading date). However, Ms. Bodem&#8217;s entitlement to any Interim CFO Subsequent Equity Grants will end, and Ms. Bodem will have no further entitlement to any Company equity grants under the Agreement, following the earliest of (i) the appointment of a permanent Chief Financial Officer of the Company prior to an applicable monthly anniversary of the Interim CFO Final Vesting Date; (ii) Ms. Bodem&#8217;s termination of employment with the Company for any reason prior to an applicable monthly anniversary of the Interim CFO Final Vesting Date and (iii) the first day of the seventh full calendar month following the Interim CFO Final Vesting Date. To the extent Ms. Bodem&#8217;s employment as the Company&#8217;s Interim Chief Financial Officer causes her to forfeit certain group </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">health plan insurance coverage that she would otherwise have been entitled to receive in connection with her separation from a prior employer, the Company and Ms. Bodem will make arrangements in good faith to compensate her for such forfeiture and/or provide her with substantially similar group health plan insurance coverage until January 1, 2024. While Ms. Bodem is the Company&#8217;s Interim Chief Financial Officer and during the period she is employed by the Company on or prior to May 6, 2022, the Company will generally reimburse or pay Ms. Bodem directly for her temporary housing expenses in Charlotte, North Carolina and reasonable costs of travel incurred by Ms. Bodem commuting between the city of Ms. Bodem&#8217;s primary residence and her principal office in accordance with the Company&#8217;s expense reimbursement policy. Ms. Bodem will be solely responsible for any taxable income recognized by her in connection with such temporary housing and commuting expenses and will not be entitled to any tax gross up payments or other reimbursement from the Company in connection therewith. The Company will also reimburse Ms. Bodem for other reasonable travel and business expenses incurred by her in the performance her duties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of Ms. Bodem&#8217;s employment agreement is qualified in its entirety by reference to the text of Ms. Bodem&#8217;s Agreement filed as Exhibit 10.2 and incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Bodem does not have any family relationship with any director or executive officer of the Company, or person nominated or chosen by the Company to become a director or executive officer, and she has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will also enter into its standard form of indemnification agreement with Ms. Bodem, the form of which is filed as Exhibit 10.19(b) to the Company&#8217;s Form 10-K for the period ended December 31, 2021.</span></div><div><span><br/></span></div><div id="i2b88dce5853c480cbeb75588f15674b8_127"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 7.01 Regulation FD Disclosure.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 19, 2022, the Company issued a press release announcing that Mr. Casey </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has been terminated as the Company&#8217;s Chief Executive Officer and has ceased to serve as a member of the Board of Directors of the Company, effective as of April 19, 2022; provided that Mr. Casey will remain employed by the Company through May 6, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information furnished in Items 7.01 and 9.01 to this Form 8-K, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></div><div><span><br/></span></div><div id="i2b88dce5853c480cbeb75588f15674b8_13"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.081%"><tr><td style="width:1.0%"></td><td style="width:10.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d) Exhibits:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit No. </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interim Chief Executive Officer Employment Agreement by and between DENTSPLY SIRONA Inc. and John P. Groetelaars, dated April 16, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interim Chief Financial Officer Employment Agreement by and between DENTSPLY SIRONA Inc. and Barbara W. Bodem, dated April 16, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DENTSPLY SIRONA Inc. press release, dated April 19, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Date File (embedded within the Inline XBRL Document)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i2b88dce5853c480cbeb75588f15674b8_16"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">SIGNATURE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;DENTSPLY SIRONA Inc.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.432%"><tr><td style="width:1.0%"></td><td style="width:15.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.039%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.181%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cher&#233;e H. Johnson</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cher&#233;e H. Johnson</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President &#8211; Chief Legal </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Officer, General Counsel and Secretary</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: April 19, 2022</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i50dfd1d4e4864b58ac69a83f102ec8c3_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Interim Chief Executive Officer </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Employment Agreement</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Interim Chief Executive Officer Employment Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), is entered into as of April 16, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) by and between DENTSPLY SIRONA Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and John P. Groetelaars (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) (collectively referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RECITALS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive and the Company mutually desire that Executive provide services to the Company on the terms provided herein.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AGREEMENT</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements set forth below, the Parties hereto agree as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and Executive desire that Executive be employed as the Company&#8217;s Interim Chief Executive Officer. Executive&#8217;s employment with the Company as its Interim Chief Executive Officer shall commence on April 19, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). Executive shall cease to be the Company&#8217;s Interim Chief Executive Officer on the first day a permanent or successor Chief Executive Officer approved by the Company&#8217;s Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) commences employment with the Company, and, unless otherwise determined by the Board, Executive shall cease to be employed by the Company on such date. Notwithstanding the foregoing, at all times Executive&#8217;s employment with the Company shall be &#8220;at-will,&#8221; such that Executive&#8217;s employment may be terminated by the Company or Executive at any time and for any reason.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Position, Reporting and Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. While serving as the Company&#8217;s Interim Chief Executive Officer, Executive shall report to the Board, shall have such duties, authority, and responsibilities as are customary for such position in a Delaware corporation (subject to the control of the Board and its committees), and shall perform such other duties as may be reasonably requested by the Board, including without limitation assisting the Board in the hiring of a permanent Chief Executive Officer for the Company.  Executive shall devote substantially all of Executive&#8217;s working time and efforts to the business and affairs of the Company (which shall include service to its &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; (within the meaning of Rule 12b-2 promulgated under Section 12 of the Exchange Act)), provided that (i) Executive shall be permitted to manage Executive&#8217;s personal, financial and legal affairs, subject to compliance with this Agreement and (ii) Executive shall be permitted to serve on the board of directors of up to two (2) publicly traded or privately held companies.  Executive agrees to observe and comply with the rules and policies of the Company and its Affiliates as adopted by the Company or its Affiliates from time to time, in each case as amended from time to time, as set forth in writing, and as delivered or made available to Executive (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Principal Place of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive&#8217;s principal office shall be the Company&#8217;s facility in Sarasota, Florida, or such other offices as may be appropriate for the performance of his duties as mutually agreed by the Board and Executive.  The Parties understand that given the nature of Executive&#8217;s duties, Executive may be required to travel and perform services at locations other than his principal office from time to time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Certain Executive Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive represents and warrants that (i) Executive is not subject to any impediment, restriction or restraint that would in any way prohibit, hinder or impair his employment hereunder and his performance as contemplated hereby, and (ii) without limiting the foregoing, Executive&#8217;s employment hereunder and his performance as contemplated hereby do not and would not in any way conflict with or breach any confidentiality, non-competition or other agreement to which he is a party or to which he may be subject.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Compensation and Related Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Initial RSU Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall grant to Executive an award of Restricted Share Units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) under the DENTSPLY SIRONA Inc. 2016 Omnibus Incentive Plan, as amended and restated (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), with the number of Company common shares (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) subject to such grant having a grant date fair value of seven million dollars ($7,000,000) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Initial RSU Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The number of shares subject to the Initial RSU Grant shall be calculated by dividing (x) seven million dollars ($7,000,000) by (y) the closing price of a Company share as listed on The Nasdaq Global Select Market on the Initial RSU Grant&#8217;s grant date. The Initial RSU Grant&#8217;s grant date shall be the third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) trading day after the Commencement Date, provided, that, if such grant date is not within the Company&#8217;s open trading window period, the Initial RSU Grant&#8217;s grant date shall instead be the third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) trading day after the date of the filing of the next periodic report on Form 10-Q following the Commencement Date. The Initial RSU Grant shall vest monthly with respect to the shares subject thereto in six substantially equal installments, with the first vesting date occurring on the one month anniversary of the Commencement Date, such that one hundred percent (100%) of the shares subject to the Initial RSU Grant shall be vested on the sixth month anniversary of the Commencement Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Final Vesting Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), subject to Executive&#8217;s continued employment with the Company on each applicable vesting date as Interim Chief Executive Officer. Notwithstanding the foregoing, upon (i) the consummation of a Change in Control (as defined below) of the Company, (ii) Executive ceasing to serve as the Company&#8217;s Interim Chief Executive Officer, or (iii) Executive&#8217;s termination of employment with the Company, in each case, prior to the Final Vesting Date for any reason other than (x) a termination by the Company or its Affiliates for &#8220;Cause&#8221; (as defined below) or (y) a voluntary resignation by Executive (excluding a termination of Executive&#8217;s employment with the Company due to Executive&#8217;s death or disability), subject to Executive (or Executive&#8217;s estate, if applicable) signing on or before the sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) day following Executive&#8217;s termination of employment with the Company or cessation of service as Interim Chief Executive Officer (if applicable), and not revoking, a release of claims in the Company&#8217;s customary form, as it may be updated from time to time, but excluding any restrictive covenants that may otherwise be included in the customary form (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Release Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), one hundred percent (100%) of any then-unvested portion of the Initial RSU Grant shall become vested. For the avoidance of doubt, the termination of Executive's employment or cessation of Executive&#8217;s service as Interim Chief Executive Officer, in each case, in connection with the appointment of a permanent Chief Executive Officer of the Company shall, subject to Executive's satisfaction of the Release Condition, result in the accelerated vesting of one hundred percent (100%) of the then-unvested portion of the Initial RSU Grant.  The Initial RSU Grant shall be subject to and governed by the terms and conditions of the applicable Restricted Share Unit Grant Notice, Restricted Share Unit Agreement and the Plan. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Subsequent Equity Grants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If, following the Final Vesting Date, Executive continues to be employed by the Company as its Interim Chief Executive Officer under this Agreement, then as consideration for Executive&#8217;s continued employment as the Company&#8217;s Interim Chief Executive Officer through any monthly anniversary of the Final Vesting Date, the Company shall grant to Executive an award of fully vested shares under the Plan that shall be issued on the first day of the calendar month following the applicable monthly anniversary of the Final Vesting Date (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsequent Equity Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). Each Subsequent Equity Grant shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">subject to and governed by the Plan and shall have a grant date fair value of one million one hundred sixty-six thousand six hundred sixty-seven dollars ($1,166,667), with the number of shares calculated by dividing (x) one million one hundred sixty-six thousand six hundred sixty-seven dollars ($1,166,667) by (y) the closing price of a Company share as listed on The Nasdaq Global Select Market on the Subsequent Equity Grant&#8217;s grant date (or if no such shares are traded on such date, the immediately preceding date on which shares of the Company's common stock were publicly traded on The Nasdaq Global Select Market).  Notwithstanding the foregoing, Executive&#8217;s entitlement to any Subsequent Equity Grants shall end, and Executive shall have no further entitlement to any Company equity grants hereunder, following the earliest of (i) the appointment of a permanent Chief Executive Officer of the Company prior to an applicable monthly anniversary of the Final Vesting Date&#59; (ii) Executive&#8217;s termination of employment with the Company for any reason prior to an applicable monthly anniversary of the Final Vesting Date and (iii) the first day of the seventh (7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) full calendar month following the Final Vesting Date.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Prior Health Plan Coverage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the extent Executive&#8217;s employment with the Company under this Agreement causes Executive to forfeit group health plan insurance coverage for Executive and his eligible dependents that he would otherwise have been entitled to receive in connection with his separation from a prior employer under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and&#47;or under the terms of Executive&#8217;s contractual severance arrangements with such prior employer, the Parties shall make arrangements in good faith to compensate Executive for such forfeiture and&#47;or provide Executive with substantially similar group health plan insurance coverage at no greater cost to Executive.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Executive shall be entitled to coverage under the Company&#8217;s directors and officers insurance policy and indemnification pursuant to the Company&#8217;s By-Laws and certificate of incorporation, in each case in accordance with the terms and conditions thereof and on a basis no less favorable than that applicable to other executive officers of the Company from time to time. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Director Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive shall not receive any compensation for his Board service while he is employed by the Company pursuant to this Agreement and shall not be eligible for any equity grant(s) that may be awarded to other members of the Board while he is employed by the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Business Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company shall reimburse Executive for all reasonable travel and other business expenses incurred by Executive in the performance of Executive&#8217;s duties to the Company during his employment with the Company in accordance with the Company&#8217;s expense reimbursement Policy, provided that the Company agrees that (i) Executive&#8217;s travel to any of the Company&#8217;s offices other than his principal office shall be considered business travel and the associated expenses shall be considered business expenses and shall be reimbursed to Executive by the Company and (ii) for all business air travel, Executive shall be entitled to travel by first class or business class commercial flights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or private air travel and the associated cost shall be reimbursed to Executive by the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Clawback Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based compensation, or any other compensation, paid to Executive pursuant to this Agreement or any other agreement or arrangement with the Company which is subject to recovery under any Policy approved by the Board that is generally applicable to executive officers of the Company, applicable law, government regulation or stock exchange listing requirement, will be subject to such deductions and clawback as are required to be made pursuant to such Policy, law, government regulation or stock exchange listing requirement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Assignment and Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company may assign its rights and obligations under this Agreement to a United States subsidiary of the Company that is the main operating company of the Company (or the principal employer of employees of the Company and its subsidiaries) in the United States or to any successor to all or substantially all</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of the business or the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">assets of the Company (by merger or otherwise).  This Agreement shall be binding upon and inure to the benefit of the Company, Executive and the Company&#8217;s successors, assigns, personnel and legal representatives, executors, administrators, heirs, distributees, devisees, and legatees, as applicable.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Certain Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall have &#8220;Cause&#8221; to terminate Executive&#8217;s employment hereunder upon&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">a majority of the members of the Board, excluding Executive as applicable, determining that (a) Executive has committed an act of fraud in the course of his employment against the Company, or (b) Executive has committed an act of willful misconduct or gross negligence against the Company that is materially injurious to the Company or its customers&#59; </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">a majority of the members of the Board, excluding Executive as applicable, determining that Executive has willfully failed to adequately perform material duties or obligations under this Agreement&#59; </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">Executive&#8217;s indictment for, or conviction of, or pleading no contest to, a felony or a crime involving Executive&#8217;s moral turpitude, relating to Executive&#8217;s job position, or that causes substantial damage to the Company&#8217;s public image or reputation, or causes substantial harm to the Company&#8217;s operations or financial performance&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">a material breach of any of the representations and warranties set forth in Section 1(d). </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The determination as to whether Executive is being terminated for Cause shall be made after a reasonable and good faith investigation by the Board (excluding Executive as applicable)&#59; provided, however, that Cause shall not exist under this Agreement unless the Company gives written notice to Executive where such notice describes with particularity the alleged act(s) at issue and has given Executive an opportunity to be heard at a meeting of the Board at his sole discretion with or without counsel and the Board provides Executive a summary of its findings.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#8220;Change in Control&#8221; shall have the meaning set forth in the Plan as in effect on the Commencement Date. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  &#8220;Exchange Act&#8221; shall mean the Securities Exchange Act of 1934, as amended from time to time.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in accordance with the substantive laws of the Commonwealth of Pennsylvania without reference to the principles of conflicts of law of the Commonwealth of Pennsylvania or any other jurisdiction, and where applicable, the laws of the United States. The Company and Executive agree that any and all disputes relating to or arising out of this Agreement will first be submitted to mediation pursuant </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">to a written demand for mediation which either Party may serve on the other which shall be before a mediator selected by the Parties in accordance with mediation procedures of the American Arbitration Association (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">AAA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  In the event the Parties are unable to agree to a mediator within ten (10) days of receipt of the written demand for mediation, the mediator will be appointed by the office of AAA in Philadelphia, Pennsylvania.  The cost of the mediator and fees imposed by AAA shall be split equally by the Parties.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in this Agreement, the provisions of Sections 3 through 4 and this Section 6 will survive the termination of Executive&#8217;s employment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or refusal of receipt) and shall be in writing and delivered personally or sent by facsimile or certified or registered mail, postage prepaid, as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">If to the Company, to the attention of the General Counsel at its headquarters,</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">If to Executive, at the last address that the Company has in its personnel records for Executive, or</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">At any other address as any Party shall have specified by notice in writing to the other Party.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together will constitute one and the same Agreement.  Signatures delivered by facsimile or by electronic PDF shall be deemed effective for all purposes.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect to the subject matter hereof and supersede all prior understandings and agreements, whether written or oral.  The Parties further intend that this Agreement shall constitute the complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Amendments&#59; Waivers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by Executive and a duly authorized officer of the Company (other than Executive).  By an instrument in writing similarly executed, Executive or a duly authorized officer of the Company (other than Executive) may waive compliance by the other Party with any specifically identified provision of this Agreement that such other Party was or is obligated to comply with or perform&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure.  No failure to exercise and no delay in exercising any right, remedy, or power hereunder preclude any other or further exercise of any other right, remedy, or power provided herein or by law or in equity.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be deemed drafted equally by both the Parties.  Its language shall be construed as a whole and according to its fair meaning.  Any presumption or principle that the language is to be construed against any Party shall not apply.  The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation.  Any references to sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary.  Also, unless the context clearly </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">indicates to the contrary, (i) the plural includes the singular and the singular includes the plural&#59; (ii) &#8220;and&#8221; and &#8220;or&#8221; are each used both conjunctively and disjunctively&#59; (iii) &#8220;any,&#8221; &#8220;all,&#8221; &#8220;each,&#8221; or &#8220;every&#8221; means &#8220;any and all,&#8221; and &#8220;each and every&#8221;&#59; (iv)&#160;&#8220;includes&#8221; and &#8220;including&#8221; are each &#8220;without limitation&#8221;&#59; (v) &#8220;herein,&#8221; &#8220;hereof,&#8221; &#8220;hereunder&#8221; and other similar compounds of the word &#8220;here&#8221; refer to the entire Agreement and not to any particular section or subsection&#59; and (vi) all pronouns and any variations thereof shall be deemed to refer to the masculine, feminine, neuter, singular or plural as the identity of the entities or persons referred to may require.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Enforcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If any provision of this Agreement is held to be illegal, invalid or unenforceable, such provision shall be fully severable&#59; this Agreement shall be construed and enforced as if such illegal, invalid or unenforceable provision had never comprised a portion of this Agreement&#59; and the remaining provisions of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid or unenforceable provision or by its severance from this Agreement.  Furthermore, in lieu of such illegal, invalid or unenforceable provision there shall be added automatically as part of this Agreement a provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible and be legal, valid and enforceable.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall be entitled to withhold from any amounts payable under this Agreement any federal, state, local or foreign withholding or other taxes or charges which the Company is legally required to withhold.  The Company shall be entitled to rely on an opinion of counsel if any questions as to the amount or requirement of withholding shall arise.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:24.69pt">General.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement and the payments and benefits thereunder are intended to be exempt from, or to the extent subject thereto, comply with Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. The Company makes no representation that any or all of the payments or benefits described in this Agreement will be exempt from or comply with Section 409A and makes no undertaking to preclude Section 409A from applying to any such payment.  Executive shall be solely responsible for the payment of any taxes and penalties incurred under Section 409A.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:21.36pt">Specified Employee.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything in this Agreement to or any other agreement providing compensatory payments to Executive to the contrary, if Executive is deemed by the Company at the time of Executive&#8217;s &#8220;separation from service&#8221; with the Company within the meaning of Section 409A (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to be a &#8220;specified employee&#8221; for purposes of Section 409A, any payment of compensation or benefits to which Executive is entitled under this Agreement or any other compensatory plan or agreement that is considered nonqualified deferred compensation under Section 409A payable as a result of Executive&#8217;s Separation from Service shall be delayed to the extent required in order to avoid a prohibited distribution under Section 409A until the earlier of (i) the expiration of the six-month period measured from the date of Executive&#8217;s Separation from Service with the Company or (ii) the date of Executive&#8217;s death.  Upon the first business day following the expiration of the applicable Section 409A period, all payments deferred pursuant to the preceding sentence shall be paid in a lump sum to Executive (or Executive&#8217;s estate or beneficiaries), and any remaining payments due to Executive under this Agreement or any other compensatory plan or agreement shall be paid as otherwise provided herein or therein.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:18.03pt">Expense Reimbursements.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To the extent that any reimbursements under this Agreement are subject to Section 409A, any such reimbursements payable to Executive shall be paid to Executive no later than December 31 of the year following the year in which the expense was incurred&#59; provided, that Executive submits Executive&#8217;s reimbursement request promptly following the date the expense is incurred, the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, and Executive&#8217;s right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:18.69pt">Separate Identified Payments.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of Section 409A, each amount to be paid or benefit to be provided under the Agreement shall be construed as a separate identified payment for purposes of Section 409A.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Executive Acknowledgement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive acknowledges that Executive has read and understands this Agreement, is fully aware of its legal effect, has not acted in reliance upon any representations or promises made by the Company other than those contained in writing herein, and has entered into this Agreement freely based on Executive&#8217;s own judgment.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div style="text-align:justify"><font><br></font></div></div></div><div id="i50dfd1d4e4864b58ac69a83f102ec8c3_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Parties have executed this Agreement effective as of the date and year first above written.</font></div><div style="margin-top:24pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DENTSPLY SIRONA Inc.</font></div><div style="margin-top:24pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Eric K. Brandt&#160;&#160;&#160;&#160;</font></div><div style="padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Eric K. Brandt</font></div><div style="padding-left:273.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Non-Executive Chairman of the Board of Directors</font></div><div style="margin-top:24pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTIVE</font></div><div style="margin-top:24pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; John P. Groetelaars&#160;&#160;&#160;&#160;</font></div><div style="padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;John P. Groetelaars</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page to Employment Agreement&#93;</font></div><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i331e0ea96aa9491a9fee3752e6420eff_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Interim Chief Financial Officer</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Employment Agreement</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Interim Chief Financial Officer Employment Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), is entered into as of April 16, 2022 by and between DENTSPLY SIRONA Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and Barbara W. Bodem (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) (collectively referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RECITALS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive and the Company mutually desire that Executive provide services to the Company on the terms provided herein.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AGREEMENT</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements set forth below, the Parties hereto agree as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and Executive desire that Executive be employed by the Company as the Company&#8217;s Interim Chief Financial Officer. Executive&#8217;s employment with the Company shall commence on April 25, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and Executive shall be appointed as the Company&#8217;s Interim Chief Financial Officer effective on or after the Commencement Date upon the earlier of (i) the effective date of termination of employment from the Company of the individual who was serving as the Company&#8217;s Chief Financial Officer on or immediately prior to the Commencement Date and (ii) close of business on May 6, 2022. Executive shall cease to be or cease to be entitled to become the Company&#8217;s Interim Chief Financial Officer on the first day a permanent or successor Chief Financial Officer approved by the Company&#8217;s Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) commences employment with the Company, and, unless otherwise determined by the Board, Executive shall cease to be employed by the Company on such date. Notwithstanding the foregoing, at all times Executive&#8217;s employment with the Company shall be &#8220;at-will,&#8221; such that Executive&#8217;s employment may be terminated by the Company or Executive at any time and for any reason.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Position, Reporting and Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. While employed by the Company on or prior to May 6, 2022 or serving as the Company&#8217;s Interim Chief Financial Officer, Executive shall report to the Interim Chief Executive Officer or Chief Executive Officer (as applicable), shall have such duties, authority, and responsibilities as are customary for Executive&#8217;s position in a Delaware corporation (subject to the control of the Board and its committees), and shall perform such other duties as may be reasonably requested by the Board.  Executive shall devote substantially all of Executive&#8217;s working time and efforts to the business and affairs of the Company (which shall include service to its &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; (within the meaning of Rule 12b-2 promulgated under Section 12 of the Exchange Act)), provided that Executive shall be permitted to manage Executive&#8217;s personal, financial and legal affairs, subject to compliance with this Agreement and provided that such activities do not materially interfere with Executive&#8217;s performance of Executive&#8217;s duties and responsibilities hereunder.  Executive agrees to observe and comply with the rules and policies of the Company and its Affiliates as adopted by the Company or its Affiliates from time to time, in each case as amended from time to time, as set forth in writing, and as delivered or made available to Executive (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Principal Place of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive&#8217;s principal office shall be the Company&#8217;s commercial headquarters in Charlotte, North Carolina, or such other offices as may </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">be appropriate for the performance of her duties as determined in consultation with the Board.  The Parties understand that given the nature of Executive&#8217;s duties, Executive may be required to travel and perform services at locations other than her principal office from time to time.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Certain Executive Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive represents and warrants that (i) Executive is not subject to any impediment, restriction or restraint that would in any way prohibit, hinder or impair her employment hereunder and her performance as contemplated hereby, (ii) without limiting the foregoing, Executive&#8217;s employment hereunder and her performance as contemplated hereby do not and would not in any way conflict with or breach any confidentiality, non-competition or other agreement to which she is a party or to which she may be subject and (iii) Executive has not been the subject of any allegation and, to her knowledge, she has not, (A) breached any law, regulation or code of conduct applicable to her in the course of employment or (B) engaged in any act of workplace misconduct or impropriety, including any act of discrimination or harassment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Compensation and Related Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Monthly Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Executive shall be entitled to receive a cash payment of one hundred thousand dollars ($100,000) less applicable deductions and withholdings (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Monthly Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) for each Applicable Month (as defined below), which shall generally be paid in accordance with the Company&#8217;s customary payroll practices and in any event no later than thirty (30) days following the Applicable Month. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Month</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean any one month period for which Executive remained employed with the Company as its Interim Chief Financial Officer for at least one day, with such month measured beginning from the Commencement Date or a monthly anniversary of the Commencement Date, provided that, in any event, the one month period commencing on the Commencement Date shall be an Applicable Month subject to Executive&#8217;s employment with the Company for at least one day during such month. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Initial RSU Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the Board&#8217;s approval, the Company shall grant to Executive an award of Restricted Share Units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) under the DENTSPLY SIRONA Inc. 2016 Omnibus Incentive Plan, as amended and restated (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), with the number of Company common shares (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) subject to such grant having a grant date fair value of two million dollars ($2,000,000) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Initial RSU Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The number of shares subject to the Initial RSU Grant shall be calculated by dividing (x) two million dollars ($2,000,000) by (y) the closing price of a Company share as listed on The Nasdaq Global Select Market on the Initial RSU Grant&#8217;s grant date. The Initial RSU Grant&#8217;s grant date shall be the third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) trading day after the Commencement Date, provided, that, if such grant date is not within the Company&#8217;s open trading window period, the Initial RSU Grant&#8217;s grant date shall instead be the third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) trading day after the date of the filing of the next periodic report on Form 10-Q or 10-K following the Commencement Date. The Initial RSU Grant shall vest monthly with respect to the shares subject thereto in six substantially equal installments, with the first vesting date occurring on the one month anniversary of the Commencement Date, such that one hundred percent (100%) of the shares subject to the Initial RSU Grant shall be vested on the sixth month anniversary of the Commencement Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Final Vesting Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), subject to Executive&#8217;s continued employment with the Company on each applicable vesting date as Interim Chief Financial Officer. Notwithstanding the foregoing, upon (i) the consummation of a Change in Control (as defined below) of the Company, (ii) Executive ceasing to serve as the Company&#8217;s Interim Chief Financial Officer, or (iii) Executive&#8217;s termination of employment with the Company, in each case, prior to the Final Vesting Date for any reason other than (x) a termination by the Company or its Affiliates for &#8220;Cause&#8221; (as defined below) or (y) a voluntary resignation by Executive (excluding a termination of Executive&#8217;s employment with the Company due to Executive&#8217;s death or disability), subject to Executive signing on or before the sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) day following Executive&#8217;s termination of employment with the Company or cessation of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">service as Interim Chief Financial Officer (if applicable), and not revoking, a release of claims in the Company&#8217;s customary form, as it may be updated from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Release Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), one hundred percent (100%) of any then-unvested portion of the Initial RSU Grant shall become vested. For the avoidance of doubt, the termination of Executive's employment in connection with the appointment of a permanent Chief Financial Officer of the Company shall, subject to Executive's satisfaction of the Release Condition, result in the accelerated vesting of one hundred percent (100%) of the then-unvested portion of the Initial RSU Grant. The Initial RSU Grant shall be subject to and governed by the terms and conditions of the applicable Restricted Share Unit Grant Notice, Restricted Share Unit Agreement and the Plan. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Subsequent Equity Grants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If, following the Final Vesting Date, Executive continues to be employed by the Company as its Interim Chief Financial Officer under this Agreement, then as consideration for Executive&#8217;s continued employment as the Company&#8217;s Interim Chief Financial Officer through any monthly anniversary of the Final Vesting Date, the Company shall grant to Executive an award of fully vested shares under the Plan that shall be issued on the first day of the calendar month following the applicable monthly anniversary of the Final Vesting Date, in each case, subject to the Board&#8217;s approval (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsequent Equity Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). Each Subsequent Equity Grant shall be subject to and governed by the Plan and shall have a grant date fair value of three hundred thirty-three thousand three hundred thirty-three dollars ($333,333), with the number of shares calculated by dividing (x) three hundred thirty-three thousand three hundred thirty-three dollars ($333,333) by (y) the closing price of a Company share as listed on The Nasdaq Global Select Market on the Subsequent Equity Grant&#8217;s grant date (or if no such shares are traded on such date, the immediately preceding date on which shares of the Company's common stock were publicly traded on The Nasdaq Global Select Market). Notwithstanding the foregoing, Executive&#8217;s entitlement to any Subsequent Equity Grants shall end, and Executive shall have no further entitlement to any Company equity grants hereunder, following the earliest of (i) the appointment of a permanent Chief Financial Officer of the Company prior to an applicable monthly anniversary of the Final Vesting Date&#59; (ii) Executive&#8217;s termination of employment with the Company for any reason prior to an applicable monthly anniversary of the Final Vesting Date and (iii) the first day of the seventh (7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) full calendar month following the Final Vesting Date.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Prior COBRA Coverage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the extent Executive&#8217;s employment with the Company under this Agreement causes her to forfeit group health plan insurance coverage for Executive under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) that she would otherwise have been entitled to receive in connection with her separation from a prior employer, the Parties shall make arrangements in good faith to compensate Executive for such forfeiture and&#47;or provide Executive with substantially similar group health plan insurance coverage until January 1, 2024. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Executive shall be entitled to indemnification pursuant to the Company&#8217;s By-Laws in accordance with the terms and conditions thereof, subject to Executive&#8217;s appointment as the Company&#8217;s Interim Chief Financial Officer. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Temporary Residence&#59; Commuting Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  During the period that Executive serves as the Company&#8217;s Interim Chief Financial Officer under this Agreement and during the period that Executive is employed by the Company on or prior to May 6, 2022, to the extent that Executive&#8217;s principal residence is more than one hundred (100) miles from her principal office, the Company shall reimburse or pay directly Executive for (i) her temporary housing expenses in Charlotte, North Carolina on a basis no less favorable than that otherwise provided under the Company&#8217;s Relocation Program for Vice Presidents and more senior employees (as such Relocation Program may be amended from time to time) and (ii) reasonable costs travel incurred in commuting on a regular basis between the city of Executive&#8217;s primary residence and her principal office in accordance with the Company&#8217;s expense reimbursement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Policy. Executive shall be solely responsible for any taxable income recognized by her in connection with such temporary housing expenses and commuting expenses and shall not be entitled to any tax gross up payments or other reimbursement from the Company in connection therewith.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Business Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company shall reimburse Executive for all reasonable travel and other business expenses incurred by Executive in the performance of Executive&#8217;s duties to the Company during her employment with the Company in accordance with the Company&#8217;s expense reimbursement Policy.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Clawback Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based compensation, or any other compensation, paid to Executive pursuant to this Agreement or any other agreement or arrangement with the Company which is subject to recovery under any Policy approved by the Board that is generally available to senior management of the Company, applicable law, government regulation or stock exchange listing requirement, will be subject to such deductions and clawback as may be required to be made pursuant to such Policy, law, government regulation or stock exchange listing requirement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Assignment and Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company may assign its rights and obligations under this Agreement to a United States subsidiary of the Company that is the main operating company of the Company (or the principal employer of employees of the Company and its subsidiaries) in the United States or to any successor to all or substantially all</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of the business or the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">assets of the Company (by merger or otherwise).  This Agreement shall be binding upon and inure to the benefit of the Company, Executive and the Company&#8217;s successors, assigns, personnel and legal representatives, executors, administrators, heirs, distributees, devisees, and legatees, as applicable.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Certain Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall have &#8220;Cause&#8221; to terminate Executive&#8217;s employment hereunder upon&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">a majority of the members of the Board determining that (a) Executive has committed an act of fraud in the course of her employment against the Company, or (b) Executive has committed an act of willful misconduct or gross negligence against the Company that is materially injurious to the Company or its customers&#59; </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">a majority of the members of the Board determining that Executive has willfully failed to adequately perform material duties or obligations under this Agreement&#59; </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">Executive&#8217;s indictment for, or conviction of, or pleading no contest to, a felony or a crime involving Executive&#8217;s moral turpitude, relating to Executive&#8217;s job position, or that causes substantial damage to the Company&#8217;s public image or reputation, or causes substantial harm to the Company&#8217;s operations or financial performance&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">a material breach of any of the representations and warranties set forth in Section 1(d). </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The determination as to whether Executive is being terminated for Cause shall be made after a reasonable and good faith investigation by the Board&#59; provided, however, that Cause shall not </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">exist under this Agreement unless the Company gives written notice to Executive where such notice describes with particularity the alleged act(s) at issue and has given Executive an opportunity to be heard at a meeting of the Board at her sole discretion with or without counsel and the Board provides Executive a summary of its findings.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#8220;Change in Control&#8221; shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  &#8220;Exchange Act&#8221; shall mean the Securities Exchange Act of 1934, as amended from time to time.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in accordance with the substantive laws of the Commonwealth of Pennsylvania without reference to the principles of conflicts of law of the Commonwealth of Pennsylvania or any other jurisdiction, and where applicable, the laws of the United States. The Company and Executive agree that any and all disputes relating to or arising out of this Agreement will first be submitted to mediation pursuant to a written demand for mediation which either Party may serve on the other which shall be before a mediator selected by the Parties in accordance with mediation procedures of the American Arbitration Association (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">AAA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  In the event the Parties are unable to agree to a mediator within ten (10) days of receipt of the written demand for mediation, the mediator will be appointed by the office of AAA in Philadelphia, Pennsylvania.  The cost of the mediator and fees imposed by AAA shall be split equally by the Parties.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in this Agreement, the provisions of Sections 3 through 4 and this Section 6 will survive the termination of Executive&#8217;s employment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or refusal of receipt) and shall be in writing and delivered personally or sent by facsimile or certified or registered mail, postage prepaid, as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">If to the Company, to the attention of the General Counsel at its headquarters,</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">If to Executive, at the last address that the Company has in its personnel records for Executive, or</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">At any other address as any Party shall have specified by notice in writing to the other Party.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together will constitute one and the same Agreement.  Signatures delivered by facsimile or by electronic PDF shall be deemed effective for all purposes.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect to the subject matter hereof and supersede all prior understandings and agreements, whether written or oral.  The Parties further intend that this Agreement shall constitute the complete and exclusive statement of their terms </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Amendments&#59; Waivers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by Executive and a duly authorized officer of the Company (other than Executive).  By an instrument in writing similarly executed, Executive or a duly authorized officer of the Company (other than Executive) may waive compliance by the other Party with any specifically identified provision of this Agreement that such other Party was or is obligated to comply with or perform&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure.  No failure to exercise and no delay in exercising any right, remedy, or power hereunder preclude any other or further exercise of any other right, remedy, or power provided herein or by law or in equity.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be deemed drafted equally by both the Parties.  Its language shall be construed as a whole and according to its fair meaning.  Any presumption or principle that the language is to be construed against any Party shall not apply.  The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation.  Any references to sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary.  Also, unless the context clearly indicates to the contrary, (i) the plural includes the singular and the singular includes the plural&#59; (ii) &#8220;and&#8221; and &#8220;or&#8221; are each used both conjunctively and disjunctively&#59; (iii) &#8220;any,&#8221; &#8220;all,&#8221; &#8220;each,&#8221; or &#8220;every&#8221; means &#8220;any and all,&#8221; and &#8220;each and every&#8221;&#59; (iv)&#160;&#8220;includes&#8221; and &#8220;including&#8221; are each &#8220;without limitation&#8221;&#59; (v) &#8220;herein,&#8221; &#8220;hereof,&#8221; &#8220;hereunder&#8221; and other similar compounds of the word &#8220;here&#8221; refer to the entire Agreement and not to any particular section or subsection&#59; and (vi) all pronouns and any variations thereof shall be deemed to refer to the masculine, feminine, neuter, singular or plural as the identity of the entities or persons referred to may require.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Enforcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If any provision of this Agreement is held to be illegal, invalid or unenforceable, such provision shall be fully severable&#59; this Agreement shall be construed and enforced as if such illegal, invalid or unenforceable provision had never comprised a portion of this Agreement&#59; and the remaining provisions of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid or unenforceable provision or by its severance from this Agreement.  Furthermore, in lieu of such illegal, invalid or unenforceable provision there shall be added automatically as part of this Agreement a provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible and be legal, valid and enforceable.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall be entitled to withhold from any amounts payable under this Agreement any federal, state, local or foreign withholding or other taxes or charges which the Company is required to withhold or by its Policies it customarily withholds.  The Company shall be entitled to rely on an opinion of counsel if any questions as to the amount or requirement of withholding shall arise.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:24.69pt">General.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement and the payments and benefits thereunder are intended to be exempt from, or to the extent subject thereto, comply with Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. The Company makes no representation that any or all of the payments or benefits described in this Agreement will be exempt from or comply with Section 409A and makes no undertaking to preclude Section 409A from applying to any such payment.  Executive </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall be solely responsible for the payment of any taxes and penalties incurred under Section 409A.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:21.36pt">Specified Employee.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything in this Agreement to or any other agreement providing compensatory payments to Executive to the contrary, if Executive is deemed by the Company at the time of Executive&#8217;s &#8220;separation from service&#8221; with the Company within the meaning of Section 409A (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to be a &#8220;specified employee&#8221; for purposes of Section 409A, any payment of compensation or benefits to which Executive is entitled under this Agreement or any other compensatory plan or agreement that is considered nonqualified deferred compensation under Section 409A payable as a result of Executive&#8217;s Separation from Service shall be delayed to the extent required in order to avoid a prohibited distribution under Section 409A until the earlier of (i) the expiration of the six-month period measured from the date of Executive&#8217;s Separation from Service with the Company or (ii) the date of Executive&#8217;s death.  Upon the first business day following the expiration of the applicable Section 409A period, all payments deferred pursuant to the preceding sentence shall be paid in a lump sum to Executive (or Executive&#8217;s estate or beneficiaries), and any remaining payments due to Executive under this Agreement or any other compensatory plan or agreement shall be paid as otherwise provided herein or therein.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:18.03pt">Expense Reimbursements.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To the extent that any reimbursements under this Agreement are subject to Section 409A, any such reimbursements payable to Executive shall be paid to Executive no later than December 31 of the year following the year in which the expense was incurred&#59; provided, that Executive submits Executive&#8217;s reimbursement request promptly following the date the expense is incurred, the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, and Executive&#8217;s right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:18.69pt">Separate Identified Payments.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of Section 409A, each amount to be paid or benefit to be provided under the Agreement shall be construed as a separate identified payment for purposes of Section 409A.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Executive Acknowledgement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive acknowledges that Executive has read and understands this Agreement, is fully aware of its legal effect, has not acted in reliance upon any representations or promises made by the Company other than those contained in writing herein, and has entered into this Agreement freely based on Executive&#8217;s own judgment.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div style="text-align:justify"><font><br></font></div></div></div><div id="i331e0ea96aa9491a9fee3752e6420eff_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Parties have executed this Agreement effective as of the date and year first above written.</font></div><div style="margin-top:24pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DENTSPLY SIRONA Inc.</font></div><div style="margin-top:24pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Eric K. Brandt&#160;&#160;&#160;&#160;</font></div><div style="padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Eric K. Brandt</font></div><div style="padding-left:273.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Non-Executive Chairman of the Board of Directors</font></div><div style="margin-top:24pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTIVE</font></div><div style="margin-top:24pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Barbara W. Bodem&#160;&#160;&#160;&#160;</font></div><div style="padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Barbara W. Bodem</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page to Employment Agreement&#93;</font></div><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>exhibit991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ice6425f5bb77440eac36f1004048ca6e_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:123px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Dentsply Sirona Provides Corporate Update</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">John Groetelaars Named Interim Chief Executive Officer</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Barbara Bodem Named Interim Chief Financial Officer</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Company Provides Update on Anticipated First Quarter Financial Results</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CHARLOTTE, N.C.,&#160;April 19, 2022 (GLOBE NEWSWIRE) --</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> DENTSPLY SIRONA Inc. (&#8220;Dentsply Sirona&#8221; or &#8220;the Company&#8221;) (Nasdaq&#58; XRAY)&#160;today announced the appointment of John Groetelaars, who serves on Dentsply Sirona&#8217;s Board of Directors, as Interim Chief Executive Officer. He succeeds Don Casey, who has been terminated as CEO and will cease to serve as a member of the Company&#8217;s Board, effective immediately. The Board has initiated a search to identify the Company&#8217;s next CEO and has retained a leading executive search firm to support the process.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Eric Brandt, Non-Executive Chairman of the Board stated, &#8220;We are pleased to welcome John as Dentsply Sirona&#8217;s Interim CEO. John has a strong track record of driving innovative business strategies, and as a seasoned executive with more than 30 years of industry experience, he is uniquely positioned to lead our company during this transition period. John is the right leader to bring continuity and guide Dentsply Sirona&#8217;s execution of its key strategic initiatives to create sustainable value for our shareholders. As the Board conducts its search for a permanent CEO, we are focused on finding a candidate with a track record of world-class execution and operational expertise who can position the Company for the future.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mr. Groetelaars commented, &#8220;I look forward to serving as Interim CEO during this important time for the Company. I joined the Company&#8217;s Board because of my deep appreciation for our mission and unwavering commitment to innovation, operational excellence and providing positive outcomes for patients and customers. Dentsply Sirona is situated in attractive, growing dental categories and has a strong foundation in place, built on its portfolio of leading products and differentiated position across key markets. The Board is confident that renewing the Company&#8217;s focus on execution will stabilize the business and deliver strong performance despite ongoing macroeconomic challenges. This will be my focus from day one, and I am prepared to leverage my prior executive leadership experience as I work with the rest of the Board and management team to drive the Company&#8217;s strategy and advance its vision to transform dentistry and improve oral health globally.&#8221; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mr. Brandt continued, &#8220;On behalf of the Board, I would like to thank Don for his many contributions to our company. Don has played a key role in strengthening our foundation and advancing our mission to create innovative solutions for healthy smiles. We wish him all the best in his future endeavors.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Appointment of Interim CFO </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dentsply Sirona also today announced the appointment of Barbara Bodem as Interim Chief Financial Officer, effective upon Jorge Gomez&#8217;s previously announced departure on May 6, 2022. Ms. Bodem will join the Company on April 25, 2022, and work closely with Mr. Gomez to ensure a seamless transition.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ms. Bodem is an accomplished executive with over two decades of financial leadership experience in the healthcare industry, most recently serving as Senior Vice President and CFO of Hillrom. Previously, Barbara served in senior leadership roles at Mallinckrodt Pharmaceuticals, Hospira and Eli Lilly and Company.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mr. Brandt said, &#8220;We are fortunate to welcome Barbara, a proven finance executive, as our interim CFO during this transition period. Barbara brings extensive expertise in healthcare with an international perspective, having served in multiple leadership roles across finance organizations at global companies. As we continue our search for a permanent CFO, we believe that Barbara and our talented financial team will continue to deliver value for our patients, business partners and shareholders.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Select Preliminary Financial Results for the First Quarter of 2022</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dentsply Sirona today also provided an update on its anticipated financial results for the first quarter ending March 31, 2022. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">On a preliminary basis, the Company expects that net sales will be approximately $965 million (representing an organic sales decline of approximately 1.4% versus prior year). Additionally, GAAP diluted earnings per share will be in the range of $0.26 - $0.30 and adjusted earnings per share will be in the range of $0.48 - $0.52.&#160;Relative to last year, these results reflect weaker sales performance in the U.S., global supply chain challenges, and foreign exchange headwinds.&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company will provide further information on its results and 2022 outlook when it releases its earnings as scheduled on May 5, 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The amounts set forth above are preliminary estimates. The Company is in the process of finalizing its results of operations for the first quarter ended March 31, 2022 and therefore final results are not yet available. These preliminary estimates are based solely upon information available to management as of the date of this press release. The Company&#8217;s actual results may differ from these estimates due to the completion of its quarter-end closing procedures, final adjustments and developments that may arise or information that may become available between now and the time the Company&#8217;s financial results for the first quarter ended March 31, 2022 are finalized. The Company&#8217;s unaudited consolidated financial statements for the first quarter ended March 31, 2022 should be consulted once they become available.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">About John Groetelaars</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">John Groetelaars served as President, CEO and a Board member at Hillrom from May 2018 until the company&#8217;s acquisition by Baxter International, Inc., in December 2021. At Hillrom, Mr. Groetelaars led a transformation of the business, successfully articulating and launching a new connected-care strategy and vision, growing the portfolio through seven acquisitions and one divestiture, and driving record financial performance. Prior to Hillrom, Mr. Groetelaars served as Executive Vice President and President of the Interventional Segment at Becton, Dickinson and Company following its acquisition of C.R. Bard Inc. He previously served in a variety of progressive roles at C.R. Bard during his 10-year career there, including as a group president from 2015 to 2017. Prior to joining C.R. Bard, Mr. Groetelaars held various international leadership positions in Canada, Denmark and the United Kingdom at Boston Scientific Corporation from 2001 until 2008. Prior to joining Boston Scientific, Mr. Groetelaars held positions in general management, marketing, business development and sales with Guidant Corporation and with Eli Lilly. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mr. Groetelaars earned a Bachelor of Science in Mechanical Engineering from Kettering University and an MBA from Columbia Business School.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">About Barbara Bodem</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Barbara Bodem most recently served as Senior Vice President and Chief Financial Officer for Hillrom, where she was responsible for both Financial and Information Technology and oversaw portfolio transformation and performance acceleration. She also served as Interim CIO during the pandemic. Prior to her positions at Hillrom, Ms. Bodem served as Senior Vice President of Finance for Mallinckrodt Pharmaceuticals, Vice President of Finance, Global Commercial Operations for Hospira, and at several positions of increasing responsibility at Eli Lilly and Company, culminating in Chief Financial Officer, Lilly Oncology. Ms. Bodem also has extensive Board experience, and currently serves as Audit Committee Chair for Turning Point Therapeutics, as a Director on Syneos&#8217; Board, and as a Director on Enovis Corporation&#8217;s Board. She has also previously served as a board member for Invacare Corporation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ms. Bodem earned and a Bachelor of Science in Finance with honors and minors in Economics and East Asian Studies, as well as an MBA from Indiana University.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">About Dentsply Sirona</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dentsply Sirona is the world&#8217;s largest manufacturer of professional dental products and technologies, with a 135-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona&#8217;s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry. The Company&#8217;s shares of common stock are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Non-GAAP Financial Measures</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company has provided certain measures in this press release that are not calculated in accordance with US GAAP and therefore represent Non-GAAP measures. These Non-GAAP measures may differ from those used by other companies and should not be considered in isolation from, or as a substitute for, measures of financial performance prepared in accordance with US GAAP. These Non-GAAP measures are used by the Company to measure its performance and may differ from those used by other companies.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Management believes that these Non-GAAP measures are helpful as they provide another measure of the results of operations, and are frequently used by investors and analysts to evaluate the Company&#8217;s performance exclusive of certain items that impact the comparability of results from period to period, and which may not be indicative of past or future performance of the Company.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company is not able to reconcile projected adjusted earnings per share (non-GAAP) to first quarter 2022 projected earnings per share (GAAP) without unreasonable efforts because it is not possible to predict with a reasonable degree of certainty the actual impact of the tax rate and related matters for the quarter ended March 31, 2022. The unavailable information could have a significant impact on the Company&#8217;s first quarter 2022 reported financial results.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Forward-Looking Statements</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All statements in this press release that do not directly and exclusively relate to historical facts constitute &#8220;forward-looking statements.&#8221; These statements represent current expectations and beliefs, including statements regarding preliminary financial information for the first quarter ending March 31, 2022, and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">described in such statements, many of which are outside of our control. Furthermore, many of these risks and uncertainties are currently amplified by and may continue to be amplified by or may, in the future, be amplified by, the novel coronavirus (&#8220;COVID-19&#8221;) pandemic and the impact of varying private and governmental responses that affect our customers, employees, vendors and the economies and communities where they operate. For a written description of these factors, see the section titled &#8220;Risk Factors&#8221; in Dentsply Sirona&#8217;s Annual Report on Form 10-K for the most recent fiscal year. No assurance can be given that any expectation, belief, goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of press release or to reflect the occurrence of unanticipated events.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Contact Information</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investors&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Andrea Daley</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VP, Investor Relations</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">+1-704-805-1293</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">InvestorRelations&#64;dentsplysirona.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Press&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Marion Par-Weixlberger</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VP, Corporate Communications and PR</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">+43 676 848414588</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">marion.parweixlberger&#64;dentsplysirona.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>xray-20220416.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:97ea7f8f-ff86-4c34-be4c-873ef9505afa,g:f3ae1ec0-38c5-41c5-9ea8-168f861349c2-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xray="http://www.dentsplysirona.com/20220416" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dentsplysirona.com/20220416">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xray-20220416_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xray-20220416_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xray-20220416_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.dentsplysirona.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>xray-20220416_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:97ea7f8f-ff86-4c34-be4c-873ef9505afa,g:f3ae1ec0-38c5-41c5-9ea8-168f861349c2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.dentsplysirona.com/role/CoverPage" xlink:type="simple" xlink:href="xray-20220416.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.dentsplysirona.com/role/CoverPage" xlink:type="extended" id="i6e5a0f57a2c94d9aae6e196f42e9bf40_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsLineItems_bb682f1b-991a-4637-8461-ebdff725ed64" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9ff8419e-e54d-49f6-98b2-84582a112603" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityListingsLineItems_bb682f1b-991a-4637-8461-ebdff725ed64" xlink:to="loc_dei_TradingSymbol_9ff8419e-e54d-49f6-98b2-84582a112603" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6bf12aa2-3c32-49a4-83ec-d695ba38f4ef" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityListingsLineItems_bb682f1b-991a-4637-8461-ebdff725ed64" xlink:to="loc_dei_Security12bTitle_6bf12aa2-3c32-49a4-83ec-d695ba38f4ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_35a754cf-da5e-4600-9ba5-ebc95974d739" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityListingsLineItems_bb682f1b-991a-4637-8461-ebdff725ed64" xlink:to="loc_dei_SecurityExchangeName_35a754cf-da5e-4600-9ba5-ebc95974d739" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_19f99989-ee60-4f06-b76c-73a24adda0e7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityListingsLineItems_bb682f1b-991a-4637-8461-ebdff725ed64" xlink:to="loc_dei_DocumentType_19f99989-ee60-4f06-b76c-73a24adda0e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsTable_e9eddd17-670f-4922-b4f5-a2e32538d80e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityListingsLineItems_bb682f1b-991a-4637-8461-ebdff725ed64" xlink:to="loc_dei_EntityListingsTable_e9eddd17-670f-4922-b4f5-a2e32538d80e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>xray-20220416_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:97ea7f8f-ff86-4c34-be4c-873ef9505afa,g:f3ae1ec0-38c5-41c5-9ea8-168f861349c2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_d0da4085-97bb-4ca8-8e9b-dd2fff35c554_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_0a9d093f-f635-43d6-8bdc-ee9bdf0c5bfb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_282098a4-96b3-4d62-b898-17a663ac7cca_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_03ee32a1-c9d4-45ad-836f-3d6e10787f26_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6999fd1d-1317-4388-90f4-dc0ae82f6213_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_ed98e17b-5a0f-4314-85e6-d967e942177b_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_925ebeb3-bd44-4fe0-96ed-3d2fcf28b3c7_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8d1d228a-505d-483e-a790-c7c49b13690a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_8f49b8f4-7956-4127-aaa9-c67636927d18_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_d0ce3841-9aae-4048-bf97-fc5c030d4e03_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_ead303f1-59d7-4974-82e7-567e68800e9a_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_1678f9bf-bcee-440a-b0c5-6234d0f3ca9a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_05ca0c48-03a7-469e-a5c6-2847ba877556_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_00a309a4-0e2d-4cd3-bb79-6231f1d1adc9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1aedf4c9-5bd0-4f43-bfcf-0b9dc5bc3816_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_9a3d9d88-3745-4af6-b048-b5322396dbb2_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_21ef173f-f18a-446c-a88e-10b7867a5a95_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8d19277b-3a3c-461c-9c5e-804a4ed60446_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_65ea5016-01cf-42e8-83df-451b24909d38_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_0448a0f2-8cbb-4c0c-b656-d30ca8cbdaad_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsLineItems_e878aca7-d365-4ddc-b823-02560d6731d9_terseLabel_en-US" xlink:label="lab_dei_EntityListingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings [Line Items]</link:label>
    <link:label id="lab_dei_EntityListingsLineItems_label_en-US" xlink:label="lab_dei_EntityListingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsLineItems" xlink:to="lab_dei_EntityListingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsTable_7c50279b-dc33-455c-af32-b4b3f6965be6_terseLabel_en-US" xlink:label="lab_dei_EntityListingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings [Table]</link:label>
    <link:label id="lab_dei_EntityListingsTable_label_en-US" xlink:label="lab_dei_EntityListingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsTable" xlink:to="lab_dei_EntityListingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_9b750261-848b-4972-b42a-c963b13f596d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_c4a85e77-ce3e-439b-b47b-4227b09a4712_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b9995e9f-0719-4b0b-ae53-c97795f2981f_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>xray-20220416_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:97ea7f8f-ff86-4c34-be4c-873ef9505afa,g:f3ae1ec0-38c5-41c5-9ea8-168f861349c2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dentsplysirona.com/role/CoverPage" xlink:type="simple" xlink:href="xray-20220416.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.dentsplysirona.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_c390dbdb-1499-4843-8bc7-3a6fa772af5d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_EntityCentralIndexKey_c390dbdb-1499-4843-8bc7-3a6fa772af5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_7ef21727-e9e4-49a5-a5f3-72cd48647093" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_AmendmentFlag_7ef21727-e9e4-49a5-a5f3-72cd48647093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_355c75f5-92c3-4b54-bd87-eb9210d387eb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_DocumentType_355c75f5-92c3-4b54-bd87-eb9210d387eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_90fe803d-f715-4476-ab26-475dc8f48f50" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_DocumentPeriodEndDate_90fe803d-f715-4476-ab26-475dc8f48f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7810d8f2-4e32-41f3-b7bb-900012ea0920" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_EntityRegistrantName_7810d8f2-4e32-41f3-b7bb-900012ea0920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_68180bc0-ed39-4bb2-8a79-17fad1271b3a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_EntityIncorporationStateCountryCode_68180bc0-ed39-4bb2-8a79-17fad1271b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b88cd770-4eb6-4f73-ac33-eb73071c42ed" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_EntityFileNumber_b88cd770-4eb6-4f73-ac33-eb73071c42ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_9df1b792-281a-4e43-a3ed-d57533962342" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_EntityTaxIdentificationNumber_9df1b792-281a-4e43-a3ed-d57533962342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a2eb9b4b-cf18-4b4e-9558-bce6a6f8f1fd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_EntityAddressAddressLine1_a2eb9b4b-cf18-4b4e-9558-bce6a6f8f1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b11c9967-b4a2-4a38-806f-93090c3f59e2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_EntityAddressCityOrTown_b11c9967-b4a2-4a38-806f-93090c3f59e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f944eee7-ea5c-4604-af08-5aca0ee9e375" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_EntityAddressStateOrProvince_f944eee7-ea5c-4604-af08-5aca0ee9e375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_918b3187-ccf2-4a30-8a53-e113661fd2f3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_EntityAddressPostalZipCode_918b3187-ccf2-4a30-8a53-e113661fd2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_695fdefa-d412-4525-b77c-07a50c4c0e74" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_CityAreaCode_695fdefa-d412-4525-b77c-07a50c4c0e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_12ad81b1-aa5e-4f1a-8b8e-bc168d1a86df" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_LocalPhoneNumber_12ad81b1-aa5e-4f1a-8b8e-bc168d1a86df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_decbb249-351e-4aa1-af85-91f1b77c5014" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_WrittenCommunications_decbb249-351e-4aa1-af85-91f1b77c5014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_792c129d-f11b-4037-a675-83c18a3c2a20" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_SolicitingMaterial_792c129d-f11b-4037-a675-83c18a3c2a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_d9a01774-c375-4de3-9278-f40c1f9517bb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_PreCommencementTenderOffer_d9a01774-c375-4de3-9278-f40c1f9517bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_f410c7e0-173c-4140-a1cf-c37e4943f0ff" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_f410c7e0-173c-4140-a1cf-c37e4943f0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_c7520dc5-d30b-4f41-a994-251d5614e21e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_Security12bTitle_c7520dc5-d30b-4f41-a994-251d5614e21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3dc9e55a-854f-463f-86f6-4e3cae827b10" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_TradingSymbol_3dc9e55a-854f-463f-86f6-4e3cae827b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_303da178-df47-43c3-bf18-6817a0f32f9c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_SecurityExchangeName_303da178-df47-43c3-bf18-6817a0f32f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_56459e50-068b-4196-af68-39d512d8085f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_EntityEmergingGrowthCompany_56459e50-068b-4196-af68-39d512d8085f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsTable_e9eddd17-670f-4922-b4f5-a2e32538d80e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingsTable"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d6d91f6b-dfae-46b5-bff2-27dd5b9dae16" xlink:to="loc_dei_EntityListingsTable_e9eddd17-670f-4922-b4f5-a2e32538d80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsLineItems_bb682f1b-991a-4637-8461-ebdff725ed64" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingsLineItems"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsTable_e9eddd17-670f-4922-b4f5-a2e32538d80e" xlink:to="loc_dei_EntityListingsLineItems_bb682f1b-991a-4637-8461-ebdff725ed64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9ff8419e-e54d-49f6-98b2-84582a112603" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsLineItems_bb682f1b-991a-4637-8461-ebdff725ed64" xlink:to="loc_dei_TradingSymbol_9ff8419e-e54d-49f6-98b2-84582a112603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6bf12aa2-3c32-49a4-83ec-d695ba38f4ef" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsLineItems_bb682f1b-991a-4637-8461-ebdff725ed64" xlink:to="loc_dei_Security12bTitle_6bf12aa2-3c32-49a4-83ec-d695ba38f4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_35a754cf-da5e-4600-9ba5-ebc95974d739" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsLineItems_bb682f1b-991a-4637-8461-ebdff725ed64" xlink:to="loc_dei_SecurityExchangeName_35a754cf-da5e-4600-9ba5-ebc95974d739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_19f99989-ee60-4f06-b76c-73a24adda0e7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsLineItems_bb682f1b-991a-4637-8461-ebdff725ed64" xlink:to="loc_dei_DocumentType_19f99989-ee60-4f06-b76c-73a24adda0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !^ GX# 2(  A$! Q$!_\0
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M[^E*(E_NC\JR>,I]*:.F.6UUO69^5"_\%+?VAC_$W_A-C_XBI%_X*4_M#?\
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M\9_\)_\ ^PK].?+7^ZOY4>2OI7/+"S>TS:-:"^R?F6O_  4/^/&/O'_P0?\
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MC[#%_P \U_*L)>&&>O;.:OW&BXRRO_H6T_O_ . ?#"_MB?%@_P 3_P#@H_\
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M;76+?1;NYFM[9M1MU@DN/*;8SJ%=LKN#+G/WD;CBO1: "BBB@ HHHH ****
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M  3;_9R\-_%3_@HA\1OB9X3>\N_A3X-U*Z;POYR%;5M2O$07#6Z'Y=B*' P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDNB"/+R53:K(I'S=>M?HI112;!*P4444AA1110 4444 %%%% !1110 4444
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MCX#>+6G_ &@='M_A_P"+/'WC+P3-IUZ_B>;Q(+F:TTZ1?+^R-!<7,:/YSL9
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..BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140143119945352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Apr. 16, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000818479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 16,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DENTSPLY SIRONA Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-16211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">39-1434669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">13320 Ballantyne Corporate Place,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Charlotte<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">28277-3607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">844)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">848-0137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XRAY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XRAY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>xray-20220416_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="xray-20220416.xsd" xlink:type="simple"/>
    <context id="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000818479</identifier>
        </entity>
        <period>
            <startDate>2022-04-16</startDate>
            <endDate>2022-04-16</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF80L2ZyYWc6OWJjZTE2ZDM2YTYxNDMyOWFjOWUxMGI5NjIyNmE3NjkvdGFibGU6NGY4NjljOTkxNzk3NGIwM2FmZTQ4NWQxMzY3NDNiZWEvdGFibGVyYW5nZTo0Zjg2OWM5OTE3OTc0YjAzYWZlNDg1ZDEzNjc0M2JlYV8wLTEtMS0xLTgzNDA3_c832c17d-1e0b-44d1-bba7-d00b9cec0b1a">0000818479</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF80L2ZyYWc6OWJjZTE2ZDM2YTYxNDMyOWFjOWUxMGI5NjIyNmE3NjkvdGFibGU6NGY4NjljOTkxNzk3NGIwM2FmZTQ4NWQxMzY3NDNiZWEvdGFibGVyYW5nZTo0Zjg2OWM5OTE3OTc0YjAzYWZlNDg1ZDEzNjc0M2JlYV8xLTEtMS0xLTgzNDA3_c0a231e5-ff7d-49d0-8f75-973ee4a5b598">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF8xNTk4_36d6e7b8-8384-4297-825f-44a783c1b505">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF8xNjAw_97616079-1316-4da2-8d4f-65c2d25b136d">2022-04-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF8xNjAx_b3f5966f-10cb-436f-b27c-ea478c990d00">DENTSPLY SIRONA Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18wLTAtMS0xLTgzNDA3_d669b1a7-d5fc-4506-a39a-3d213defe8bb">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18wLTEtMS0xLTgzNDA3_85f4b7b6-42c9-4531-aba2-5ce0338f8851">0-16211</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18wLTMtMS0xLTgzNDA3_ed361c23-8626-4445-a84d-a25ef2c032e2">39-1434669</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18zLTAtMS0xLTgzNDA3_eb56c063-6547-448e-8f03-e57d0457879b">13320 Ballantyne Corporate Place,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18zLTEtMS0xLTgzNDA3_2a840432-858f-4e8e-b789-bca1c4f32bf8">Charlotte</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18zLTItMS0xLTgzNDA3_8e4e8d8a-3319-40d5-9c5b-9266f3c28501">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Y2UwNTIzOWMwODAxNDNjZDg5MzUyMDFmNzY1MWU5MjcvdGFibGVyYW5nZTpjZTA1MjM5YzA4MDE0M2NkODkzNTIwMWY3NjUxZTkyN18zLTMtMS0xLTgzNDA3_8e4956e0-f86f-4728-bb26-59ea0099e0a5">28277-3607</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF8xNjAy_eaa12c7c-0332-4a98-a713-c2bdb835fb1b">844)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF8xNjAz_9852a681-95fa-47ed-9303-fc0e769e52ab">848-0137</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF82MTY_6f3f3e15-1c9b-4420-bb24-3660edcbc120">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF83MDY_48f1d321-9c09-440d-8e18-a6246b8d4580">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF83OTg_de21bdc1-8184-44d0-9167-3138772d6a76">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF85MDY_29d4628d-25cd-481c-9c20-53aecb01afbf">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Mjg2YTI0NmViNTBjNDA3YmIyMTY1ZTUwZjNjYWI2ZmIvdGFibGVyYW5nZToyODZhMjQ2ZWI1MGM0MDdiYjIxNjVlNTBmM2NhYjZmYl8xLTAtMS0xLTgzNDA3_198e2305-b854-4249-8486-a0554ab928b3">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Mjg2YTI0NmViNTBjNDA3YmIyMTY1ZTUwZjNjYWI2ZmIvdGFibGVyYW5nZToyODZhMjQ2ZWI1MGM0MDdiYjIxNjVlNTBmM2NhYjZmYl8xLTEtMS0xLTgzNDA3_0b66e601-6b58-45e2-be23-fb956b56c6b5">XRAY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGFibGU6Mjg2YTI0NmViNTBjNDA3YmIyMTY1ZTUwZjNjYWI2ZmIvdGFibGVyYW5nZToyODZhMjQ2ZWI1MGM0MDdiYjIxNjVlNTBmM2NhYjZmYl8xLTItMS0xLTgzNDA3_d2240ff2-ae10-4884-bed2-6a8618bd9758">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiODhkY2U1ODUzYzQ4MGNiZWI3NTU4OGYxNTY3NGI4L3NlYzoyYjg4ZGNlNTg1M2M0ODBjYmViNzU1ODhmMTU2NzRiOF8xL2ZyYWc6ODFkYjkyMDZhY2RiNDE3NjhjYjc1NWEwYmZiMWM3YzAvdGV4dHJlZ2lvbjo4MWRiOTIwNmFjZGI0MTc2OGNiNzU1YTBiZmIxYzdjMF8xMzQw_d9ef22e7-22cf-4d6d-b19b-5ac42a830e38">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $>&DU0'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !'AI-43EL"QN\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9)1
M2\,P$,>_BN2]O;15P=#E9<,G!<&!XEM(;EM8TX3DI-VWMXU;A^@'\#%W__SN
M=W"M#D+[B"_1!XQD,=V,KNN3T&'%#D1! "1]0*=2.27ZJ;GST2F:GG$/0>FC
MVB/4G-^#0U)&D8(96(2%R&1KM- 1%?EXQAN]X,-G[#+,:, .'?:4H"HK8'*>
M&$YCU\(5,,,(HTO?!30+,5?_Q.8.L'-R3'9)#<-0#DW.33M4\/[\])K7+6R?
M2/4:IU_)"CH%7+'+Y+=FO=D^,EGSNB[X;5$];&LN[KBHFH_9]8??5=AY8W?V
M'QM?!&4+O^Y"?@%02P,$%     @ 1X:35)E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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MX_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0
M   ( $>&DU0'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ 1X:35$Y; L;O    *P(  !$
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M;',O+G)E;'-02P$"% ,4    " !'AI-4&445]3<!   G @  #P
M    @ &<$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 1X:35"0>FZ*M
M    ^ $  !H              ( ! !(  'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ 1X:35&60>9(9 0  SP,  !,
M ( !Y1(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  +Q0
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="xray-20220416.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dentsplysirona.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="xray-20220416.htm">xray-20220416.htm</File>
    <File>ex101.htm</File>
    <File>exhibit102.htm</File>
    <File>exhibit991.htm</File>
    <File>xray-20220416.xsd</File>
    <File>xray-20220416_def.xml</File>
    <File>xray-20220416_lab.xml</File>
    <File>xray-20220416_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "xray-20220416.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "xray-20220416_def.xml"
     ]
    },
    "inline": {
     "local": [
      "xray-20220416.htm"
     ]
    },
    "labelLink": {
     "local": [
      "xray-20220416_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "xray-20220416_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "xray-20220416.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "xray",
   "nsuri": "http://www.dentsplysirona.com/20220416",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "xray-20220416.htm",
      "contextRef": "i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.dentsplysirona.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "xray-20220416.htm",
      "contextRef": "i6441cc09f47340ea97c920c9852f7f6a_D20220416-20220416",
      "decimals": null,
      "lang": "en-US",
      "name": "dei:DocumentPeriodEndDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]",
        "terseLabel": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]",
        "terseLabel": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dentsplysirona.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000818479-22-000031-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000818479-22-000031-xbrl.zip
M4$L#!!0    ( $>&DU2+ *]MER0  '+R   )    97@Q,#$N:'1M[5U9<]M(
MDG[?7X&U=]U2!'3+\CF.D&79K5FWK974XYVGB2)0),L&46@<I#B_?O.H*A1
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M,@-6M@RPS18-%!DHKE#7K<"U_*,23"KP)\&:/56"T6'X/EX^+CB*JIP#ZDS
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M'S][T7*H?HL3I^7%_#.F9M&99K]F%"6Z?^B_>W+OOOM:]QTJK3=KFK/GL:Z
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M-\QEC<"'@[*EW$$K30L/(< /F\WT$PM$0#6IV+^*JF"??4C%NIK4*U5M8:9
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M]^67<JI$AS<[.+%LEX-!K&QU6FH/55"Y$73/!@G VMBEO,<!^02?>QQ0KW!
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MT$Q-5-,T)5[2(;#EM5E1K/-[Z9/-ON5X3,'/L87(4"VU9</NJF@>;Y)H/F%
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M\#7K5\R3FUK3P!+(C3%*+FBJKJ;:R-J[C1'2JYT)4,?8-5*%,U54QE>DP3*
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MS3";CEYQ-W7;LER'U:R:X9B6ZMC,;M1JEN5IM7K#M"WLMI?"[&"&8;(YLN/
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M'<J*C<-[?Y.5E66E-2TKS#7JFJ,;BE7706!,LZ90RW05JM>8ISNJH3-];=N
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M1))]EG#W,+?ND"WA?9=1>!\&Z?J)1"*!S&3*@%O/'@N582CE&EVT0OEG)9W
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M?"\+BVZPZU&C5YI4?Y&/CF[RYV?_ U!+ P04    " !'AI-4[]$C4"P+  !
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MWHK'6_WV9)[<W,[TZKWK7,?-;F=Y7O-:HF0E2C\J4?ZU;;!)#_@'PEML8ST
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MER0  '+R   )              "  0    !E>#$P,2YH=&U02P$"% ,4
M" !'AI-4K-?F;$XF   '^P  #@              @ &^)   97AH:6)I=#$P
M,BYH=&U02P$"% ,4    " !'AI-43Q35PI 5  ![5@  #@
M@ $X2P  97AH:6)I=#DY,2YH=&U02P$"% ,4    " !'AI-4.!*SL:TH  !W
M^0  $0              @ 'T8   >')A>2TR,#(R,#0Q-BYH=&U02P$"% ,4
M    " !'AI-42^N#<( "  "1"   $0              @ '0B0  >')A>2TR
M,#(R,#0Q-BYX<V102P$"% ,4    " !'AI-4_N9Z?[4#  "J$   %0
M        @ %_C   >')A>2TR,#(R,#0Q-E]D968N>&UL4$L! A0#%     @
M1X:35._1(U L"P  0&8  !4              ( !9Y   'AR87DM,C R,C T
M,39?;&%B+GAM;%!+ 0(4 Q0    ( $>&DU1'<C&]QP<  * ]   5
M      "  <:;  !X<F%Y+3(P,C(P-#$V7W!R92YX;6Q02P4&      @ " #V
) 0  P*,

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
